Olema Pharmaceuticals, Inc. OLMA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$53.09M-74.7% | -$46.06M-37.2% | -$42.22M-22.2% | -$43.78M-44.1% | -$30.39M+1.9% | ||
| $119K-7.0% | $187K+61.2% | $43K-54.7% | $132K+40.4% | $128K+45.5% | ||
| $10.15M+132% | $4.27M-32.5% | $4.25M-24.5% | $4.69M-18.0% | $4.38M-10.8% | ||
| -$5.68M-31.8% | $5.77M+129% | —— | —— | -$4.31M-187% | ||
| -$2.6M-373% | $4.46M+134% | $0-100% | $1.86M+6,287% | -$549K+65.5% | ||
| $1.3M+112% | $3.63M+62.8% | $5.9M+1.4% | $12.7M+257% | -$11.25M-2,684% | ||
| $301K+4.9% | $301K+4.9% | $300K+4.2% | $288K+0.3% | $287K-0.3% | ||
| -$313K-1.3% | -$313K-2.6% | -$311K-2.3% | -$311K-6.1% | -$309K-18.8% | ||
| —— | -$1.57M+23.0% | -$1.57M+23.0% | -$1.57M+23.0% | -$1.57M+23.0% | ||
| -$45.99M-4.6% | -$38.33M-45.8% | -$34.53M-27.8% | -$29.88M-8.4% | -$43.98M-87.2% | ||
| $4.53M+110% | -$162.18M-41.7% | $17.27M-62.4% | —— | -$45.08M-124% | ||
| $8.43M+3,472% | $7.88M+1,236% | $41K-55.4% | $234K+239% | $236K-74.3% | ||
| $4.41M— | —— | —— | —— | —— | ||
| $45.7M+20,487% | $213.55M-12.6% | $41K-55.4% | -$2.52M-116% | $222K-97.5% | ||
| $4.25M+105% | —— | -$17.21M-191% | —— | -$88.84M-155% | ||
| —— | -$1.57M+23.0% | -$1.57M+23.0% | -$1.57M+23.0% | -$1.57M+23.0% | ||
| -$313K-1.3% | -$313K-2.6% | -$311K-2.3% | -$311K-6.1% | -$309K-18.8% | ||
| $1.3M+112% | $3.63M+62.8% | $5.9M+1.4% | $12.7M+257% | -$11.25M-2,684% | ||
| $100K-89.6% | $496K+34.8% | $3.91M+2,242% | $773K-28.4% | $965K-28.1% | ||
| -$2.6M-373% | $4.46M+134% | $0-100% | $1.86M+6,287% | -$549K+65.5% | ||
| $1.27M-39.4% | —— | $1.32M-34.0% | $1.71M-21.8% | $2.1M-10.8% | ||
| $301K+4.9% | $301K+4.9% | $300K+4.2% | $288K+0.3% | $287K-0.3% | ||
| —— | —— | —— | —— | $14K— | ||
| $237K— | —— | —— | —— | —— | ||
| $41.92M— | —— | $0— | —— | —— | ||
| —— | $51.35M— | $51.35M— | $51.35M— | $51.35M— | ||
| -$313K-1.3% | -$313K-2.6% | -$311K-2.3% | -$311K-6.1% | -$309K-18.8% | ||
| —— | -$23.75K+71.8% | -$23.75K+71.8% | -$23.75K+71.8% | -$23.75K+71.8% | ||
| —— | $44.25K-76.3% | $44.25K-76.3% | $44.25K-76.3% | $44.25K-76.3% | ||
| —— | $144.5K-91.1% | $144.5K-91.1% | $144.5K-91.1% | $144.5K-91.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Olema Pharmaceuticals, Inc. generate?
- Olema Pharmaceuticals, Inc. (OLMA) generated -$148.7M in operating cash flow over the trailing twelve months.
- What is Olema Pharmaceuticals, Inc.'s free cash flow?
- After $332.0K of capital expenditures, Olema Pharmaceuticals, Inc.'s free cash flow was -$115.4M over the trailing twelve months, down 30.9% year over year.
- Where does Olema Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Olema Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.